BioNTech to shutter sites in Germany, Singapore as no buyers emerge

German COVID‑19 vaccine maker BioNTech said on Monday it would close ​sites in Germany and Singapore because ‌it failed to find buyers after pivoting away from pandemic-era manufacturing.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。